Trial intelligence / Profile preview

Atorvastatin use in bone marrow transplantation

IRCT2014071418484N1Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Oct 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of atorvastatin in Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL), follicular lymphoma (FL) and 2 more, sponsored by Tehran University of Medical Sciences. Started Oct 2013; status: completed.

02

Drugs

atorvastatin
03

Conditions

Hodgkin lymphoma (HL)non-Hodgkin lymphoma (NHL)follicular lymphoma (FL)multiple myeloma (MM)plasma cell malignancies

Beyond the preview

Go deeper on IRCT2014071418484N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2014071418484N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call